patentgrep
SearchCompaniesTechnologiesAPIPricingDocs
DocsGet an API key
  1. Technology classes
  2. /A · Human necessities
  3. /A61 · Medical or veterinary science
  4. /A61K · Medicines and medical preparations
  5. /A61K 40/00 · Cellular immunotherapy
  6. /A61K 40/40 · Cellular immunotherapy: characterised by antigens that are targeted or presented by cells
  7. /A61K 40/41 · Vertebrate antigens
  8. /A61K 40/42 · Cancer antigens
  9. /A61K 40/4202 · Receptors, cell surface antigens or cell surface determinants
  10. /A61K 40/4214 · Receptors for cytokines
  11. /A61K 40/4218
A61K 40/4218

Receptors for interferons [ifn]

Official title: {Receptors for interferons [IFN]}

A61K40/4218 (Receptors for interferons [ifn]) appears on 1 US grants and 4 published applications in this corpus.

Search patents in A61K

Where it sits

  1. AHuman necessities
  2. A61Medical or veterinary science
  3. A61KMedicines and medical preparations
  4. A61K 40/00Cellular immunotherapy
  5. A61K 40/40Cellular immunotherapy: characterised by antigens that are targeted or presented by cells
  6. A61K 40/41Vertebrate antigens
  7. A61K 40/42Cancer antigens
  8. A61K 40/4202Receptors, cell surface antigens or cell surface determinants
  9. A61K 40/4214Receptors for cytokines
  10. A61K 40/4218Receptors for interferons [ifn]
Granted patents
1
Published applications
4
Assignees
4
Inventors
10
Latest grant
3 Feb 2026

Filings by year

Granted patentsPublished applications
A61K 40/4218: granted patents and published applications per publication year
YearGranted patentsPublished applications
202302
202401
202501
202610

2023202420252026

By publication year. 2026 runs to 8 Oct.

Recent patents

  • Chimeric antigen receptor, macrophage expressing same, method for adjusting macrophage polarization, and use thereof3 Feb 2026US 12,540,182 B2Zhejiang University
  • Improved primary human nk cell expansion and function by chimeric cytokine receptor15 May 2025US 2025/0152716 A1The Regents of the University of California
  • Bi-specific chimeric antigen receptors and genetically engineered immune cells expressing such25 Jul 2024US 2024/0245772 A1Celledit LLC
  • Chimeric antigen receptor, macrophage expressing same, method for adjusting macrophage polarization, and use thereof20 Jul 2023US 2023/0227554 A1Zhejiang University
  • Chimeric antigen receptor regenerative gamma delta t cells13 Jul 2023US 2023/0218671 A1Creative Medical Technologies, Inc.

Most cited

By later US patents

No patent in this class has been cited by a later US patent yet.

Top assignees

Documents
  • ZUZhejiang University2
  • CCelledit LLC1
  • CMCreative Medical Technologies, Inc.1
  • RUThe Regents of the University of California1

Often classified with

  • A61PTherapeutic uses of medicines4
  • C07KPeptides4
  • C12NMicroorganisms or enzymes4

Documents that also carry the other class.

patentgrep

Search every US patent grant since 1976 and every published application since 2001. Updated weekly from USPTO.

Product

  • Search
  • New this week
  • Where the data comes from
  • Pricing

Browse

  • Companies
  • Technology classes

Developers

  • API docs
  • PatentsView-compatible API
  • MCP server
  • Changelog

About

  • Privacy
  • Terms
© 2026 patentgrepData from USPTO bulk files